Molbio Diagnostics' Q1 FY 2026-27 Quarterly Results

Result Summary

• Molbio Diagnostics Ltd reported a - quarter-on-quarter (QoQ) - in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a - of -.
• Its expenses for the quarter were - by - QoQ and - - YoY.
• The net profit - - QoQ and - - YoY.
• The earnings per share (EPS) of Molbio Diagnostics Ltd stood at 5.21 during Q1 FY 2026-27.

Financial Statments for Q1 FY 2026-27

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Molbio Diagnostics Ltd is a company operating within the healthcare and diagnostics sector. The company is known for providing diagnostic solutions, although specific details about its main products or services are not available from the provided data. Generally, companies in this sector develop technologies and tools that aid in the detection and diagnosis of various diseases and health conditions. There are no recent major developments or specific updates about Molbio Diagnostics Ltd included in the provided data.

Revenue

For the first quarter of the fiscal year 2027, Molbio Diagnostics Ltd recorded a total income of ₹411.48 crores. This figure represents the entirety of the company's earnings from its operations during this period. Unfortunately, there is no available data for the previous quarters (Q4FY26 and Q1FY26) to allow for a calculation of quarter-over-quarter (QoQ) or year-over-year (YoY) changes. Consequently, no trends in revenue growth or decline can be discerned from the current dataset.

Profitability

In terms of profitability, Molbio Diagnostics Ltd reported a profit before tax of ₹75.91 crores for Q1FY27. After accounting for taxes amounting to ₹23.16 crores, the company achieved a profit after tax of ₹52.75 crores. Earnings per share for this quarter stood at ₹5.21. Like the revenue figures, there is no data available from previous quarters to assess any changes in profitability over time. Thus, comparisons and trends within profitability metrics remain uncalculated.

Operating Metrics

The total expenses for Molbio Diagnostics Ltd for Q1FY27 were ₹335.57 crores. This reflects the company's spending on operations and other related costs during the quarter. The absence of comparative data from previous quarters prevents an analysis of any operational efficiencies or inefficiencies over time. The financial ratios typically used to evaluate operating metrics, such as the current ratio or debt-to-equity ratio, cannot be calculated from the available dataset as key components like current assets, current liabilities, or total liabilities are not provided.